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Abstract:  This article examines autism policy narratives in Canada and the United States.  In 
both nations, meta-narratives emerged, establishing federal autism policy.  Whereas the stories 
associated with these meta-narratives shared starting points, the stories unfolded in nationally 
distinct ways.  
 




Policy narratives surrounding autism became more prevalent in Canada and United States 
during the past two decades (Baker & Stokes, 2007). This article explores stories, non-stories, 
counter-stories, and meta-narratives in autism policymaking using the narrative policy analysis 
approach presented by Roe (1994) with a specific focus on the 2006 Federal Autism Initiatives in 
Canada and the U.S. Combating Autism Act of 2006 (Lynch, 2006). The article begins with a 
brief overview of autism and then presents relevant aspects of narrative analysis. The 
introduction is followed by the Canadian case study and that, in turn, is followed by the United 
States case study.  The article concludes with a comparative examination of the cases of Canada 




The U.S. Centers for Disease Control and Prevention (CDC) defines autism as a 
“collection of neurologically-based developmental disorders in which individuals have 
impairments in social interaction and communication skills, along with a tendency to have 
repetitive behaviors or interests” (Centers for Disease Control 2008).  There is no scientific 
consensus as to the cause of autism spectrum disorders (hereinafter referred to as autism). 
However, most research to date focuses on genetic or environmental explanations (see, for 
example, Morrow et al., 2008).   
 
As a spectrum difference, autism presents differently in each individual identified as 
having autism (Miller 2009).  Although symptoms may emerge in early infancy, autism may not 
be considered as a diagnosis until much later in a person’s life (Twyman et al., 2009).  A young 
child who has major speech delays and sensory issues and avoids eye contact, for example, may 
be diagnosed with classical autism before his or her third birthday. However, a teenager with 
typical speech development but difficulties in social situations may not be diagnosed with high 
functioning autism (HFA) until the age of 16 or even later (Twyman et al., 2009). Diagnosis of 
autism depends on observed behavior rather than a medical test. To further complicate the 
situation, over a person’s lifespan, behaviors associated with autism may change (Miller 2009).  
  
 The inherent diversity and (perceived) mystery around autism complicate the creation of 
effective autism related public policy. For example, these factors complicate data collection on 
the prevalence and incidence of autism, both over time and across different contexts.  They also 
complicate the work of incorporating input from multiple stakeholders, such as school systems, 
health care providers, and the families of people with autism. Finally, success of interventions is 
not consistent across the population of individuals with autism. What helps one person with 
autism cope with anxiety, for example, may do nothing for a person with the same diagnosis. 
 
Narrative Policy Analysis 
 
Narrative policy analysis is particularly well suited to the case of autism policy.  Autism-
related policy is characterized by high degrees of uncertainty, ambiguity, complexity, and, in 
Roe’s words, is an area “where most everyone is playing it by ear” (Roe, 1994, p. 13). In such 
instances, those involved in the policy process rarely agree on the criteria for success. Success 
can be constructed from movements within the narratives (Kaplan, 1986). Given this, an 
understanding of policy narratives is critical to an understanding of autism policymaking because 
these narratives provide the most cohesive framework around which policy can be developed.  
 
Narrative policy analysis assumes language constructs the world.  The approach focuses 
on the importance of language in constructing policy (Bridgman & Barry, 2002, p. 141).  In this 
method, discourse surrounding an issue is the focal point rather than empirical data. Discourse 
can, in effect, “respond” to empirical data by shifting meanings without exiting the policy arena. 
Narrative policy analysis, as developed by Roe, employs a case study approach and focuses on 
“the scenarios and arguments on which policies are based” (Roe, 1994, p. 2).  It examines the 
policy narratives or “stories” developing around a complex policy issue.  Focus is placed on the 
stories or narratives that “dominate the issue in question” (Roe, p. 3).   
 
Roe also stresses the need to identify stories not fitting the traditional definition of a 
story.  These “nonstories” do not have beginnings, middles, and ends.  Furthermore, if the 
narrative “run(s) counter to the controversy’s dominant policy narratives,” it is called a 
“counterstory” (Roe, p. 3).  The narrative generated from a comparison of stories and nonstories 
or counterstories is the “metanarrative” (Roe, p. 4).  The metanarrative may then “recast(s) the 
issue in such a way as to make it more amenable to decision making and policymaking” (Roe, p. 
4).  In polarized policy disputes, the metanarrative can make the issues more tractable by 
foregoing a search for compromise and consensus in favor of a story that all can accept and can 
be the basis for moving forward in the policy process.  A metanarrative, as Roe reminds us, is a 
“small-a answer” providing “room to maneuver on an issue that has hitherto been treated as so 
uncertain, so complex, and so polarized that is affords little or no movement whatsoever” (Roe, 
p. 17).  Power and politics are involved in shaping how the issue is perceived and communicated 
and how the narratives are created and communicated (Roe, p. 14).   
 
Canada and the 2006 Federal Autism Initiatives 
 
 On November 24, 2006, the Ministry of Health announced Federal Autism Initiatives. 
These initiatives included: 
 sponsor an ASD stakeholder symposium in 2007 to further the development of 
ASD knowledge and dissemination among health care professionals, researchers, 
community groups, teachers, individuals, and family members; 
 begin exploring the establishment of a research chair focusing on effective 
treatment and intervention for ASD; 
 launch a consultation process on the feasibility of developing an ASD 
surveillance program through the Public Health Agency of Canada (PHAC) to 
help shape appropriate ASD programming and research; 
 create a dedicated page on the Health Canada Web site to guide the public to 
ASD information available through the Canadian Health Network and other 
resources; 
 designate the Health Policy Branch of Health Canada as the ASD lead for actions 
related to ASD at the Federal Health Portfolio level (Health Canada, 2006). 
 
These initiatives were novel both because of the stated goals and the fact that they came from the 
national government as opposed to the provinces. Autism related groups welcomed the 
initiatives, even if they were not fully satisfied with their content, scope, or budget 
(approximately $800,000).  Autism Society Canada explained in a press release: 
 
“We applaud the government for initiating some of the elements that ASC 
believes will help develop a comprehensive national autism strategy.  These are 
modest first steps, and we will work to ensure that many more steps are taken by 
government to meet the multifaceted needs of our other partners across Canada.” 
(Anderson, 2006) 
 
This creation of a national strategy broke from previous, provincially focused, autism policy 
trajectories. Primarily because autism issues were located in the health policy subsystem, 
defining autism as a federal concern had been no easy task.  After all, Canadian provinces of the 
Canadian federation had been almost exclusively responsible for the design of health care 
systems under the Charter of Rights and Freedoms. Establishing a federal autism initiative 
necessitated careful balancing of federal leadership on the part of a newly elected government 
with respect for traditional provincial autonomies with regard to publicly provided health care.  
In the process of creating such a balance, different stories about autism were employed within 




 The Canadian medicare system receives funding from the federal and provincial 
governments. To receive federal funding, provincial and territorial health care insurance 
programs must meet the guidelines of the Canadian Health Act (adopted in 1984) (Canada 
Health Care Act Annual Report, 2008-2009).  A fundamental component of the Act is the 
universally available provision of medically necessary health care delivered in hospitals and by 
physicians (Canada Health Care Act Annual Report, 2008-2009). Although strictly speaking, 
provincial participation under the Canadian Health Act is voluntary, the value placed on the 
federal fiscal support on the part of provinces is high enough to generally ensure compliance on 
the part of provinces. No definition of “medically necessary” appears in the Canadian Health Act 
(Commission on the Future of Health Care in Canada, 2002).  As a result, both the professional’s 
judgment and lists created by the provincial governments serve to discern which illnesses, 
differences, procedures, and treatments are covered.   
 
One story expressed in the Canadian public discussion of autism revolved around the 
theme of medical necessity.  Basically, the premise of this story was that autism is a treatable 
disease affecting a growing number of Canadian children.  In keeping with this story, the 
incidence and/or prevalence growth of autism observed in Canada in recent years was described 
as an epidemic (Senate Standing Committee on Social Affairs, 2007). 
 
In the version of the story most often told in Canadian discourse, autism can be 
effectively treated only by intensive behavior intervention, preferably applied behavior analysis. 
According to this story, for reasons ranging from miserly provincial governments to sheer lunacy 
on the part of other autism policy stakeholders, this medically necessary treatment had been 
withheld from children with autism.  The FEAT BC website described an organization 
committed to achieving universal public provision of applied behavior analysis for all children 
with autism living in Canada: 
 
“F.E.A.T. of B.C was established for another important reason – to publicize 
discrimination in B.C. against children with autism.  Specifically, it is wrong that 
children with physical disabilities have access to government health insurance 
coverage, yet children with the mental, neurological disability of autism do not 
receive treatment.” (FEAT, 2010) 
 
The penultimate expression of this story was the Supreme Court case Auton (Guardian 
ad litem of) v. British Columbia (Attorney General), [2004] 3 S.C.R. 657, 2004 SCC 78.  This 
case revolved around the question of whether or not the equality rights of children with autism 
under the Charter of Rights and Freedoms (the Canadian constitution) was violated if the 
children were not provided medically necessary treatment, particularly in the form of applied 
behavior analysis.  The decision of the provincial Supreme Court supported the parents who 
brought the case (The Learning Disabilities Association of Canada, 2008). 
 
 However, the Supreme Court of Canada reversed the decision, finding that the provinces 
were not required to provide all medically necessary treatment except for the core medical 
services (Baker 2008).  This finding created what Roe would call a “nonstory,” not providing a 
discernible beginning, middle, or end, or a redefinition of obligatory health care in Canada.  The 
remaining controversy surrounding the treatment, particularly as connected to the story of autism 
as a different way of being human as opposed to an illness or disability, also cast influential 
doubt on the story presenting ABA as a virtual cure for autism.  As is stated above, a key 
component of the 2006 Federal Autism Initiatives was the establishment of a research chair 
focusing on effective treatment and intervention for autism. This component of the initiatives 
connected back to the debates within the narratives on medical necessity left unsettled by the 
Supreme Court decision. 
 Scientifically Proven 
 
 Another influential narrative surrounding autism was rooted in the concept of scientific 
proof.  The “scientifically proven” presented intensive behavioral intervention (in particular 
ABA) as the only scientifically proven intervention for autism.  As such, the story created 
extreme urgency for providing treatment, since ABA is generally expected to be most (if not 
only) beneficial to young individuals with autism. 
 
Drawing primarily from the work of Dr. Ivar Lovaas, the story typically told in the 
Canadian public discourse was that little scientific evidence supporting the existence of other 
effective treatments for autism. In fact, expressions of this narrative typically did not address 
scientific studies of other options, such as dietary intervention.  For example, an online dialogue 
called “Riding Talk” employed this narrative as follows: 
 
“…since the 1980s the medical community has known that the application of 
Intensive Behavior Intervention (IBI) based on the principles of Applied Behavior 
Analysis (ABA) can help as many as 47% of children with autism develop to the 
extent that they are able to function as average children, indistinguishable from 
their peers.  Such medically necessary autism treatment is the core healthcare 
need of children struggling to overcome the ravages of autism. Yet, even though 
the provision of this treatment is far less costly than a lifetime of social support 
and institutionalization for untreated children, there is not even one province in 
Canada that offers autism treatment under provincial public health insurance 
programs (Medicare).” (Canada Votes, 2006) 
 
According to this narrative, the public policy challenges associated with autism were relatively 
easy to locate within the health care policy arena, and the blame for the problem was placed 
firmly on the shoulders of provincial governments failing to recognize a scientifically proven 
fact well established within the health care community. 
 
The Canadian press frequently cited the only scientifically proven treatment narrative.  
Almost always, the narrative was expressed first with a statement of the cost of the treatment (in 
the range of tens of thousands of Canadian dollars per year), followed by the description of either 
intensive behavioral intervention or ABA as the only scientifically proven treatment, and 
concluding with a description of the government’s failure to provide the treatment. 
 
 After the Auton verdict, however, the scientific proof narrative slightly decreased its 
focus on identifying a unique treatment for autism. For example, the website for the Geneva 
Center for Autism in Toronto stated: 
 
“While there is no one treatment which is entirely accepted by all professionals 
and parents as the 'only' approach to use, treatment based on the principles of 
Applied Behaviour Analysis (ABA) have been scientifically proven to facilitate 
the best outcomes for children with autism.” (Toronto Partnership for Autism 
Services, 2008) 
 Although the meaning of the quotes around “only” was open to interpretation, it appeared to 
reference Canadian public and government discourse surrounding the scientifically proven 
narrative.  
 
 The only scientifically proven narrative was controversial. Perhaps surprisingly, the 
counter-stories on scientific evidence usually did not come from or are motivated by providers or 
supporters of other types of therapies or interventions.  Evidence regarding alternative treatments 
and interventions tended to appear in less well publicized nonstories in Canada and did not 
address the science backing to the intensive behavioral interventions (Baker, 2008).  The leading 
counterstories to the scientifically proven narrative engaged the concepts of human individuality 




The most common version of the autistic rights narrative was a counterstory to both the 
medically necessary, and, less frequently, the scientifically proven story.  Whereas parents of 
children with autism and professionals in the behavioral intervention programs were the most 
fervent in expressing the scientifically proven and medically necessary stories, adults with 
autism who managed to integrate into the Canadian economy—if not society at large—were the 
most ardent in expressing the counterstory of autism rights.  
 
The basic elements of the autistic rights counterstory were: 1) autism is not a disease or—
in an inclusive society—even a disability; 2) behavioral intervention therapy is at best 
unnecessary and at worst an oppressive exercise robbing children with autism of their 
childhoods; and 3) other autism policy stakeholders, including the Canadian government, 
deliberately ignore and exclude the voices of adults with autism from related policy debates 
because they fear the truths revealed by the autistic-rights counterstory.  As a result, these 
narratives were often expressed outside the formal policy debate (although individuals such as 
Michelle Dawson were not allowed to present evidence in settings including the Supreme Court 
debate of the Auton case).   
 
Often autistic rights narratives were expressed in letters to members of government, and 
then the original letters and responses are posted on the World Wide Web.  For example, Ralph 
Smith of The Autism Project, Ontario, wrote to his government representative liberal Minister of 
Parliament Karen Redman on October 4, 2004 to request she consider materials discussing the 
rights of autistic Canadians.  She (or her office) responded in less than two weeks, citing her 
support for efforts to better identify and prevent autism.  Michelle Dawson, a staunch advocate 
of neurodiversity,
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 wrote back to her, explaining their concern about rights of adults with autism.  
Karen Redman’s response expressed her support to the Minister of Health for the designation of 
one treatment (presumably ABA) as a medically necessary treatment for autism. Ralph Smith’s 
response read: 
 
“Regarding your reply of November 18, 2004, I have not received a copy of your 
expected response from the Minister of Health.  Also I do not support the request 
which apparently you have made on my behalf.  I do not support your request for 
an amendment to the Canada Health Act.” (Smith, 2004) 
 
In another letter, Mr. Smith said the following:  
 
“I believe you have mistaken me for the parent of an autistic child, rather than the 
independent autistic adult which I am.  While mistaking current issues regarding autistic 
people is far more serious an error, I believe your oversight would equate to your 
assuming I am heterosexual when I am in fact a gay male, or in anyone assuming that you 
are heterosexual or lesbian.” (Smith, 2004)  
 
Ironically, as seen in Smith’s letter, Redman’s formulaic response began with the story of 
autistic rights—individuals with autism who considered autism to be a formative element of their 
selves within society (the “autistics”) found themselves facing passive and active discrimination 
in society.  Failing to recognize (or denying outright) the autistic identity was understood as an 
expression of bigotry similar to those experienced by all non-elite populations.  
 
 Such narratives have been a common element of modern disability studies.  Much 
conversation on disability rights in both Canada and the United States began with the statement 
“nothing about us without us” (Shapiro, 2011). These narratives portray efforts for individuals 
with disabilities as oppressive and in line with understandings of disability that, for the most part, 
blame the individual with the disability for any associated disadvantage. Often these narratives 
have called for a replacement of organizations for individuals with disabilities (or with a 
particular disability) with organizations of individuals with disabilities (Shakespeare, 2005).  In 
the Canadian public and government discourse surrounding autism, the autistic rights narrative 
tended to not be so separatist. This narrative has been heard, if not fully accepted or understood, 
in Canadian government discourse.  For example, regarding government funding of autism 
treatment, the report of the Senate’s Standing Committee on Social Affairs stated the following: 
 
“The second definition presented to the Committee was provided by other autistic 
individuals and researchers in the field.  In their view, autism (or ASD) is not a 
mental disorder; it is rather a neurological difference classified as a 
developmental disability that begins in early childhood and persists throughout 
adulthood…In their view, autistic individuals have strengths and traits not seen in 
the general population, just like “non-autistics” have strengths and weaknesses of 
their own.  Like non-autistic people, individuals with autism may suffer from 
mental health problems and illnesses, including for example depression, self-hate 
and suicidal ideation.  Those mental health problems may be exacerbated by the 
lack of knowledge about and appreciation of autism among non-autistic 
individuals.” (Senate Standing Committee on Social Affairs, 2007) 
 
The Canadian Government discourse tended to present a version of the autistic rights 
characterizing the story as an interesting (and arguably relevant) side note.  After all, the 2006 
initiatives listed individuals with autism alongside several other stakeholders (albeit towards end 
of the list) to be included in the anticipated national autism symposium. References to this 
narrative tended to be followed either by a return without comment to another narrative or a 
discussion of the responsive viewpoint that autistic rights narratives were presented only by 
extremely high functioning individuals with autism who failed to understand the plight and needs 




 The three categories of policy stories discussed above encompass classic premises of 
public activity targeting disability—those of care, cure, cause and celebration. Juxtaposition of 
any pair of these premises created tensions capable of thwarting or stalling efforts to develop and 
implement new programs or policies. The presence of these premises in the culturally dominant 
autism policy stories underscores a necessity for the employment of a metanarrative for decisions 
to be made and for action to be taken. The 2006 Federal Autism Initiative demonstrated the 
federal autism policy, and the metanarrative emphasized the perfection and protection of 
Canadian federalism. 
 
 The Canadian federalism metanarrative began on a note of good intentions. Well-
meaning citizens, groups, and even government officials wanting to improve conditions turned to 
the federal government to solve a problem. This problem in question, however, shaped daily 
lives and called for public policy sacrosanct to the provincial level of government. The challenge 
for the federal government, therefore, was to discern how to guide and support development of 
provincial programs and policies without becoming domineering or repressive.  The conclusion 
of the metanarrative was to carefully protect the Canadian federalist system by maintaining a 
high degree of provincial autonomy in health care, despite perceived costs to individuals 
(particularly children) with autism. As Pat Lynch, a ministerial candidate, puts it: 
 
“I am very reluctant to infringe on Provincial jurisdiction. I know the Liberals have done 
it repeatedly... but they are creating a real mess of things with all the side deals they are 
making…however, I do wonder why Medicare does not cover treatment of autism related 
disorders.” (Lynch, 2006)   
 
The primary role of the federal government was, as a result, understood as to provide support for 
research, including $15 from the Canadian Institutes of Health Research between 2000 and 2006, 
and to reach out to other countries to create joint research agendas (Scott, 2006). 
 
United States and the Combating Autism Act of 2006 
 
In the case of the United States autism policy, a metanarrative emerged and lead to the 
policy’s success. The metanarrative of an autism epidemic formed the basis for Congressional 
action on autism and the passage and eventual funding of the Combating Autism Act of 2006 
(Lynch, 2006).  Moreover, the metanarrative of an autism epidemic was broad and encompassing 
and did not, as a “grand” or “master” narrative can do, marginalize other narratives or substitute 
a form of autism canon.
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 Equally importantly, the epidemic metanarrative supported powerful 
advocacy groups and members of Congress and was policy relevant.   
 
Information on autism in the United States was important for establishing the context in 
which the metanarrative appears. There was no consensus in the United States as to the 
prevalence or incidence of autism. The CDC, for example, reported prevalence rates between 2 
and 6 per 1,000, or between 1 in 500 and 1 in 166.  This placed the prevalence rate for autism 
lower than the rate for mental retardation but higher than the rates for cerebral palsy, Down 
syndrome, or childhood cancer (Volkmar et al., 2004). The National Institute of Neurological 
Disorders and Stroke (NINDS) placed the rate at 3 to 6 per 1,000 (www.ninds.nih.gov). The 
CDC used figures demonstrating a 600 percent increase, from 22,644 to 141,022, of children 
classified as autistic between 1994 and 2003 (www.cdc.gov).  More recently, the Autism 
Developmental Disabilities Monitoring Network (ADDM) suggested the prevalence may be as 
high as 1 in 110 (http://www.cdc.gov/ncbddd/autism/index.html).   
 
Mercury Story, Counter-Story, and Non-Story 
 
As noted earlier, there was no scientific consensus as to the factors involved in the 
etiology of autism.  In the United States, a vocal group, including national organizations such as 
Safeminds and celebrities such as Jenny McCarthy, supported the belief that autism was caused 
by thimerosol, a mercury-based preservative in vaccines (Baker & Stokes, 2007). This lack of 
consensus as to the cause of autism, coupled with the lack of consensus as to the prevalence or 
incidence, encouraged the epidemic metanarrative.  
 
The status of organized autism advocacy and its efforts to gain federal passage of autism 
legislation also played a major role in developing the context of the epidemic metanarrative.  The 
organized autism advocacy began in 1965, when Dr. Bernard Rimland founded the first 
nationwide group devoted to autism, the Autism Society of America (ASA).  Rimland, a father 
of a child with autism, began ASA as a parent advocacy organization.  It expanded to over 
100,000 members and supporters and some 200 local chapters.  The ASA, however, had no 
major federal legislative success until the emergence of other advocacy groups, arguably because 
of the low profile of autism as a low incidence difference.  Indeed, significant policy impact at 
the federal level did not occur until 2000 with the passage of the Children’s Health Act (Lynch, 
2006).  ASA supported the legislation, but the advocacy group Cure Autism Now (CAN) was 
largely responsible for the inclusion of autism in this omnibus bill.   
 
Jonathan Shestack and Portia Iverson, parents of a son with autism, founded CAN in 
1995. As Shestack and Iverson were members of the entertainment community, CAN used their 
connections to gain congressional attention for autism.  Their efforts eventually resulted in the 
inclusion of autism in the Children’s Health Act (Lynch, 2006).  The Children’s Health Act 
mandated the establishment of the Interagency Autism Coordinating Committee (IACC) to 
coordinate autism research, programs, and activities (Lynch).  The IACC supported the federal 
policy response to autism and can enhance the government’s response to autism.   
 
As CAN was successfully advocating the inclusion of autism in the Children’s Health 
Act, Rep. Burton (R-IN) was holding hearings on the mercury and vaccine connection to autism 
(Lynch).  Altogether, Rep. Burton conducted over 20 hearings on topics related to mercury, 
vaccines, and autism, none of them led directly to major autism legislation.  Nonetheless, his 
efforts were a major factor in placing autism on the congressional agenda. 
 
The next major legislative initiative was the Combating Autism Act (CAA) of 2006. First 
introduced in 2005, the CAA became the focus of national controversy. From the perspective of 
its supporters, it was “held captive” by Rep. Joe Barton (R-TX), then Chair of the House Energy 
and Commerce Committee (Lynch, 2006).  Barton argued he was interested in his bill to reform 
the NIH and was not willing to support single-issue legislation, such as the CAA, until the 
reform was enacted. Consequently, he became the object of intense pressure from autism 
advocacy groups. Also, radio host Don Imus relentlessly campaigned against Barton, in large 
part because of his friendship with Bob and Suzanne Wright and their new organization, Autism 
Speaks.  Autism Speaks characterized Barton’s actions in particularly negative terms:  
 
“(I)n his unwillingness to act on a bill meticulously crafted over 18 months and 
unanimously passed by the United States Senate, Congressman Barton has decided to put 
politics before the welfare of our children.” (Autism Speaks, 2006)   
 
The statement, consistent with the Autism Speaks message, referred to autism as “an 
epidemic now affecting one in every 166 of our children, yet federal funding for autism remains 
woefully insufficient” (Barton, 2006).  Barton’s speech about CAA to the floor before the House 
included the possible connection between autism and vaccines and did not refer to an epidemic, 
but did present figures on incidence. 
 
Autism Speaks (now Autism Speaks, Inc.) was founded by Bob and Suzanne Wright, the 
grandparents of a child with autism, and friends of Don Imus and his wife Deirdre.  Bob Wright 
was the chair and CEO of NBC Universal and vice chair and executive officer of General 
Electric Company. Autism Speaks quickly became a major player in autism advocacy and, along 
with CAN, lobbied for the passage of the CAA.  The Wrights were thanked on the floor of the 
Senate when the CAA passed.  Congress approved the bill, and President Bush signed it into law 
on December 19, 2006.   
 
The CAA authorized spending for the early detection and treatment of autism as well as 
research and education and reauthorized and restructured the IACC.  Bob Wright and Jon 
Shestack noted when the Senate and House of Representatives approved the final version of the 
CAA, “(T)he passage of this landmark single-disease legislation signals the federal government’s 
declaration of war on the epidemic of autism” (Cure Autism Now and Autism Speaks, 2006). 
 
However, the discourse around legislative victory reflected controversy. Although Rep. 
Barton finally released the bill from the committee, the discussion from some in the autism 
community included objection to the version that became law, primarily because it removed 
earmark funding for research into the environmental causes of autism, including mercury in 
vaccines.  Deirdre Imus, in a letter to Newsweek, advanced the epidemic metanarrative while not 
dismissing a possible mercury connection by writing: 
 
“What has caused autism rates to grow so much in less than 20 years?  The idea 
that it’s just better diagnosis is, to parents and supporters of the autistic 
community, like fingernails on the chalkboard.  This epidemic is real and recent 
and cannot be explained by saying the diagnostic skills of doctors suddenly 
improved in the late 1990s.  Perhaps the number of mercury-containing vaccines 
given to children tripled in the ‘90s and resulted in a toxic tipping point, causing 
these children to regress into a disorder we call autism.” (Imus, 2006) 
 
 A-CHAMP withdrew its support for the CAA. Other organizations, such as Sensible 
Action for Ending Mercury-Induced Neurological Disorders (SAFE MINDS), supported the 
legislation, but expressed reservations.  Even before the bill became law, there was dissension 
within the Wright family.  Katie, the Wright’s daughter, and mother of their grandson with 
autism, said on the Oprah Winfrey show in April 2007 that she believes mercury in his 
vaccinations was responsible for her son’s autism. Autism Speaks responded with a disclaimer 
on its website, distancing themselves from Katie’s views. 
 
Nonetheless, the “mercury story” advanced by Rep. Burton and supported by a 
number of advocacy organizations accomplished what Roe predicted: when confronted 
with uncertainty concerning the etiology of autism, the mercury story simplified that 
reality (Roe, 1994, p. 35).  For some, the mercury connection was discredited, and 
alternatives, including environmental and or genetic factors, were suggested.  Some who 
refused to abandon the mercury story modified it.  Still, others, mainly small parent 
organizations, continued to question the validity of the scientific research, basically 
constructing a story of deception and cover up.   
 
The pressure from these groups was so great that the Senate Committee on 
Health, Education, Labor, and Pensions released the executive summary of a report on 
the allegations (Enzi, 2007).
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 The report made no conclusions concerning the safety of 
thimerosol and focused on whether or not there had been improprieties by government 
agencies or private entities, particularly the pharmaceutical companies.  These allegations 
of improprieties included conflicts of interest, instances of compromised research, and 
cover-up of the dangers posed by thimerosol.  The mercury story and the counterstory 
that autism was not caused by mercury in vaccines was joined by a nonstory, one that, 
following Roe, had no beginning, middle, or end and had no answer to what caused 




In this context, CAN and Autism Speaks turned to the metanarrative of the autism 
epidemic.  In support of the 2005 version of the Combating Autism Act, Shestack, the founder of 
CAN,  noted, “(w)e are determined to make the nation treat the autism epidemic as the crisis that 
it is” (Autism Speaks, 2008).  The most dramatic and effective use of the epidemic 
metanarrative, however, was the Autism Speaks 1 in 166 message. This story was heavily 
publicized in public service announcements and print media.
4
 As Fischer notes, “counting is also 
used as a tool of political mobilization” (Fischer, 2003, p. 171).  Autism Speaks chose to use the 
metanarrative, including the 1 in 166 number.  In an interview with Autism Spectrum Quarterly, 
Suzanne Wright, when speaking of lobbying on behalf of the CAA, noted,  
 
“…This is an epidemic and they know how serious it is.  The autism community is so 
committed to this and we really came together.  As you know, since you’ve been 
involved with autism for so many hears, the autism community can be a very disjointed 
group.  You might have your agenda and it might be worthwhile, but if you don’t have 
one voice, nobody’s going to pay attention to you.”  (Twachtman-Cullen, 2006, p. 2)  
 
Wright went on to say: 
 
“There are so many issues–research, genetics, the environment.  We can’t let the 
Senate and the full Congress point at us and say we are not together, because then 
we will not have a voice to their attention.” (Twachtman-Cullen, p. 2) 
 
 As would be expected by narrative policy analysis, there was no consensus per se as to 
whether or not an autism epidemic exists.  The Department of Health and Human Services 
(HHS) website, for example, notes: 
 
“The question of whether there is an autism epidemic requires an understanding of trends 
in autism.  Understanding autism trends is particularly difficult due to the lack of 
historical population-based tracking of autism rates and the fact that many early studies 
used different methods and a narrower definition of autism.” (Department of Health and 
Human Services, 2005) 
 
The Enzi report (2007) stated: 
 
“Autism has been called a national epidemic by the media, medical science and many 
active in the autism community but stops short itself of endorsing the existence of an 
epidemic per se.  The report accompanying the CAA presented data on the incidence and 
prevalence of autism but makes no mention of an epidemic.” (Senate Committee on 
Health, Education, Labor and Pensions, 2006, pp. 2-3)   
 
The report did state, however, “the committee encourages the CDC to examine specific trends of 
autism spectrum disorder over time” (Senate Committee on Health, Education, Labor and 
Pensions, p. 14).  In addition, President Bush’s signing statement did not mention an epidemic 
(White House, 2006, p. 1).   
 
The epidemic metanarrative was successful because it managed to transcend the mercury 
narrative, and there were no competing narratives compelling enough to counter it.  ASA’s 
official stance rejected the finding that there of no connection between vaccines and autism 
(ASA, 2004).   Both CAN and Autism Speaks carefully sidestepped the most radical form of the 
mercury narrative.  CAN, for example, sponsored a number of research initiatives, including one 
focusing on the neurotoxicity of mercury. Autism Speaks’ position was circumspect but not 
dismissive of a possible connection between mercury and autism.  The official Autism Speaks 
position was as follows: 
 
“Autism Speaks plans to strongly support a multidisciplinary research agenda on 
environmental exposures and autism.  We believe that projects acknowledging the 
role of gene-environment interaction and incorporating markers of exposure 
susceptibility and etiologic heterogeneity will be the most productive in the long-
term.  Given present knowledge, there is a fairly broad array of neurotoxic 
environmental exposures worthy of further study but, moving forward, the type 
and timing of exposures under investigation should continue to comport with 
emerging developments in autism neurobiology.” (Autism Speaks, 2010) 
 
Autism Speaks and CAN were able to secure passage of federal legislation while 
acknowledging the need for research on more controversial issues, such as a mercury/vaccine 
connection to autism.  Representative Burton supported the compromise legislation, referring to 
it as a “down payment” on what must be done to combat autism (Burton, 2008).  In the same 
statement, he remained committed to the mercury story, but fully embraced the epidemic 
metanarrative. 
 
The policy process could have responded to a known epidemic in ways not amenable to 
situations involving more uncertainty and ambiguity.  Even the suggestion of an epidemic was 
important since policymakers seek to avoid appearing unresponsive or callous in the face of such 
concerns.  The autism epidemic, in Roe’s terminology, became a “metanarrative that recasts a 
difficult policy problem in a more tractable way” (1994, p. 108). 
   
Discussion and Conclusion 
 
 Autism creates fascinating modern policy challenges in both Canada and the United 
States.  Because of a relative lack of scientific understanding, there was significant room for the 
creation of stories to establish the consensus necessary for developing public policy.  In both 
Canada and the United States, metanarratives emerged and helped to establish federal autism 
policy.  Whereas the stories associated with these metanarratives shared starting points, they 
unfolded in distinct ways. 
 
In both Canada and the United States, uncertainty surrounding current scientific evidence 
for autism-related theories created a starting point for policy stories.  However, the dominant 
stories had different endings. This implied policy trajectories. In the United States, the narratives 
surrounding the source of an autism epidemic frequently drew on contested scientific evidence.  
In Canada, the more influential stories surrounded scientific proof in support of particular 
interventions for autism.  In other words, whereas the predominant narrative on the theme of 
scientific proof surrounds causality in the United States, in Canada narratives tended to center on 
the concept and goal of a cure. 
  
Autism is not a disease in the traditional sense of the word.  In fact, many adults with 
autism (and quite a few other autism policy stakeholders) in both Canada and the United States 
take significant offense at this characterization (see, for example, the Autistic Self Advocacy 
Network at www.autisticadvocacy.org).  After all, the concept of a disease suggests wholly 
undesirable condition.  It also implies an anticipated downward trajectory of functionality.  
Finally, a disease is often something a person catches, not a fundamental element of his or her 
personhood. 
 
In both Canada and the United States, the elements of a disease narrative were invoked. 
They were not, however, fully embraced. As discussed above, in the United States, thimerosal 
was sometimes identified as the villain in the metanarrative of the autism epidemic by groups 
such as Safeminds.  Since childhood vaccines have been considered by policymakers, medical 
professionals and much of the general public to have be one of the greatest public health 
achievements of the twentieth century, this plot point of the story relatively quickly became 
divisive and politically counter-productive (Kirby, 2006).  To become successful, proponents of 
the narrative became focused on the concept of epidemic growth itself.  The epidemic narrative 
was also employed in Canada, though not as a metanarrative.  In Canada, the question of 
contagion was largely sidestepped and the epidemic concept was present in legislative discourse 
as part of stories about treatment, including what (if any) treatments are necessary and the 
attempt to establish a treatment favored by some policy entrepreneurs as the most scientifically 
proven. Whereas the stories of both Canada and the United States depend on a starting point that 
characterizes autism as a disease, the stories diverge with regard to the middles and ends found 
most compelling.  
 
This comparative study reinforces the importance of understanding the context in which 
narratives emerge and unfold.  In Canada, the emphasis was on federal funding for intervention.  
In the United States, the narratives focused on what the federal government could do in the 
absence of national healthcare, such as regulate vaccines and fund research.  These so-called 
medically necessary and scientifically proven stories, so crucial to the efforts in Canada to 
provide treatment for individuals with autism, were not the focus in the United States. The 
Canadian federalism metanarrative and the United States epidemic metanarrative were 
influenced as much if not more by the specific structures of government of the two countries as 
they were by the challenges presented by autism. As such, this history presents a useful reminder 
of the role of social construction in the creation of disability. It also demonstrates how the 
unfolding of the same scientific process can motivate markedly different policy outcomes in 
even quite similar democratic contexts.  
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 Examples can be seen online at www.neurodiversity.com and 
http://www.sentex.net/~nexus23/naa_02.html. 
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 For more information on grand or master narratives see, for example, John Harley Warner, 
“Grand Narrative and Its Discontents: Medical History and the Social Transformation of 
American Medicine,” Journal of Health Politics, Policy and Law, 29(4), 757-780. 
3
 Only the executive summary was released.  The full report was not made available to the 
public. 
4
 A series of television commercials incorporating the 1 in 166 aired during this time. 
Interestingly, incidence figures at the time to 1 in 150, a figure Autism Speaks utilizes on its 
website and in public service announcements. 
 
